LENZ Therapeutics, Inc.
LENZ- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001815776
No open-market purchases or sales by LENZ Therapeutics, Inc. insiders were filed in the last 90 days; 145 institutions reported holding it in 13F filings for Q2 2026, worth $197.3M in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in LENZ Therapeutics, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 62
- −4 vs. Q4 2022
- Shares held
- 29.7M
- +945.6K (+3.3%) vs. Q4 2022
- Total value
- $72.9M
- −$22.7M (−23.8%) vs. Q4 2022
- New holders
- 12
- 17 more added
- Sold out
- 16
- 18 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LENZ on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 145 | $197.3M |
| Q1 2026 | 146 | $303.3M |
| Q4 2025 | 161 | $561.6M |
| Q3 2025 | 166 | $1.36B |
| Q2 2025 | 114 | $725.1M |
| Q1 2025 | 105 | $541.8M |
| Q4 2024 | 95 | $573.2M |
| Q3 2024 | 78 | $444.8M |
| Q2 2024 | 65 | $327.0M |
| Q1 2024 | 55 | $362.0M |
| Q4 2023 | 63 | $81.5M |
| Q3 2023 | 67 | $75.8M |
| Q2 2023 | 66 | $81.2M |
| Q1 2023 | 62 | $72.9M |
| Q4 2022 | 66 | $95.6M |
| Q3 2022 | 63 | $93.9M |
| Q2 2022 | 63 | $83.0M |
| Q1 2022 | 63 | $185.7M |
| Q4 2021 | 58 | $431.7M |
| Q3 2021 | 60 | $587.4M |
| Q2 2021 | 51 | $981.4M |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding LENZ Therapeutics, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| EcoR1 Capital, LLC | 8,538,446 | $20.9M | 0.67% | +2,826,350+49.5% | Added |
| Samsara BioCapital, LLC | 8,459,314 | $20.7M | 4.28% | 00.0% | Unchanged |
| Tang Capital Management LLC | 2,028,466 | $4.97M | 0.74% | +928,466+84.4% | Added |
| Vanguard Group Inc | 1,234,438 | $3.02M | 0.00% | +7,522+0.6% | Added |
| Citadel Advisors LLC | 1,171,177 | $2.87M | 0.00% | −19,238−1.6% | Reduced |
| K2 Principal Fund, L.P. | 969,620 | $2.38M | 0.65% | +941,196+3,311.3% | Added |
| Prosight Management, LP | 876,666 | $2.15M | 1.03% | −39,892−4.4% | Reduced |
| Board of Trustees of The Leland Stanford Junior University | 703,071 | $1.72M | 0.16% | +243,784+53.1% | Added |
| Verition Fund Management LLC | 618,827 | $1.52M | 0.02% | +618,827 | New |
| BlackRock Inc. | 506,859 | $1.24M | 0.00% | −13,732−2.6% | Reduced |
| Laurion Capital Management LP | 503,100 | $1.23M | 0.06% | −70,500−12.3% | Reduced |
| Western Standard LLC | 495,393 | $1.21M | 1.23% | +495,393 | New |
| Federated Hermes, Inc. | 409,962 | $1.00M | 0.00% | −648,539−61.3% | Reduced |
| OUP Management Co., LLC | 406,308 | $995.5K | 1.99% | 00.0% | Unchanged |
| Privium Fund Management (UK) Ltd | 281,761 | $684.7K | 0.54% | −330,744−54.0% | Reduced |
| Geode Capital Management, LLC | 247,380 | $606.1K | 0.00% | +4,844+2.0% | Added |
| Renaissance Technologies LLC | 228,200 | $559.0K | 0.00% | −101,672−30.8% | Reduced |
| Two Sigma Advisers, LP | 208,800 | $511.6K | 0.00% | −46,400−18.2% | Reduced |
| Morgan Stanley | 204,320 | $500.6K | 0.00% | +169,022+478.8% | Added |
| Cormorant Asset Management, LP | 199,547 | $489.0K | 0.03% | 00.0% | Unchanged |
| BML Capital Management, LLC | 152,291 | $373.1K | 0.32% | +152,291 | New |
| Two Sigma Investments, LP | 143,696 | $352.1K | 0.00% | −64,671−31.0% | Reduced |
| Bridgeway Capital Management, LLC | 131,800 | $322.9K | 0.01% | +1,300+1.0% | Added |
| Aldebaran Capital, LLC | 130,000 | $318.5K | 0.33% | +130,000 | New |
| State Street Corp | 89,151 | $218.4K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 75,945 | $186.1K | 0.00% | +23,406+44.5% | Added |
| Northern Trust Corp | 73,191 | $179.3K | 0.00% | −5,543−7.0% | Reduced |
| Millennium Management LLC | 73,232 | $179.0K | 0.00% | −60,112−45.1% | Reduced |
| Cornercap Investment Counsel Inc | 66,427 | $162.7K | 0.03% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 63,451 | $155.5K | 0.00% | +29,816+88.6% | Added |
| Jane Street Group, LLC | 55,675 | $136.4K | 0.00% | +55,675 | New |
| Dimensional Fund Advisors LP | 51,758 | $126.8K | 0.00% | +2,439+4.9% | Added |
| Marquette Asset Management, LLC | 41,060 | $100.6K | 0.03% | +41,060 | New |
| Marshall Wace, LLP | 40,908 | $100.2K | 0.00% | +40,908 | New |
| Gsa Capital Partners LLP | 40,079 | $98.0K | 0.01% | −174,413−81.3% | Reduced |
| Prelude Capital Management, LLC | 32,099 | $78.6K | 0.01% | −2,100−6.1% | Reduced |
| D. E. Shaw & Co., Inc. | 30,384 | $74.4K | 0.00% | +100+0.3% | Added |
| Barclays PLC | 23,310 | $57.1K | 0.00% | +23,310 | New |
| HRT Financial LP | 19,492 | $47.0K | 0.00% | +19,492 | New |
| Annandale Capital, LLC | 17,930 | $44.0K | 0.01% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 17,740 | $43.5K | 0.00% | 00.0% | Unchanged |
| Cannell Capital LLC | 14,308 | $35.1K | 0.01% | 00.0% | Unchanged |
| Squarepoint Ops LLC | 14,113 | $34.6K | 0.00% | +14,113 | New |
| Goldman Sachs Group Inc | 13,179 | $32.3K | 0.00% | −15,423−53.9% | Reduced |
| Erste Asset Management GmbH | 11,900 | $28.7K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 8,967 | $22.0K | 0.00% | +7,441+487.6% | Added |
| Tower Research Capital LLC (TRC) | 4,816 | $11.0K | 0.00% | +2,700+127.6% | Added |
| Wells Fargo & Company | 3,356 | $8.22K | 0.00% | +3+0.1% | Added |
| Advisor Group Holdings, Inc. | 3,090 | $7.57K | 0.00% | 00.0% | Unchanged |
| Lazard Asset Management LLC | 2,716 | $6.00K | 0.00% | +510+23.1% | Added |
| JPMorgan Chase & Co | 1,467 | $4.00K | 0.00% | −2,444−62.5% | Reduced |
| Quantbot Technologies LP | 1,600 | $3.92K | 0.00% | 00.0% | Unchanged |
| Nordwand Advisors, LLC | 1,000 | $2.45K | 0.00% | +1,000 | New |
| China Universal Asset Management Co., Ltd. | 788 | $1.93K | 0.00% | +197+33.3% | Added |
| Pacific Center for Financial Services | 750 | $1.84K | 0.00% | +750 | New |
| Citigroup Inc | 663 | $1.62K | 0.00% | −70,492−99.1% | Reduced |
| Federation des caisses Desjardins du Quebec | 200 | $490 | 0.00% | 00.0% | Unchanged |
| State of Wyoming | 178 | $436 | 0.00% | −7−3.8% | Reduced |
| Acadian Asset Management LLC | 227 | $0 | 0.00% | −25,572−99.1% | Reduced |
| Daiwa Securities Group Inc. | 169 | $0 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 7 | $0 | 0.00% | 00.0% | Unchanged |
| Steward Financial Group LLC | 13 | $0 | 0.00% | 00.0% | Unchanged |
| Avidity Partners Management LP | 0 | $0 | 0.00% | −1,575,000−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −1,116,123−100.0% | Sold out |
| Artal Group S.A. | 0 | $0 | 0.00% | −700,000−100.0% | Sold out |
| Oasis Management Co Ltd. | 0 | $0 | 0.00% | −255,102−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −111,798−100.0% | Sold out |
| Anson Funds Management LP | 0 | $0 | 0.00% | −112,176−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −82,400−100.0% | Sold out |
| 683 Capital Management, LLC | 0 | $0 | 0.00% | −52,306−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −28,463−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −27,103−100.0% | Sold out |
| Belvedere Trading LLC | 0 | $0 | 0.00% | −22,121−100.0% | Sold out |
| Bailard, Inc. | 0 | $0 | 0.00% | −15,866−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −14,833−100.0% | Sold out |
| Lodestar Private Asset Management LLC | 0 | $0 | 0.00% | −14,199−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −13,968−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −3,346−100.0% | Sold out |